Buffett Buys Google, Novo Nordisk Cuts Obesity Drug Prices, and Public Launches AI Brokerage
The Rundown
00:00
Novo Nordisk Lowers Weight-Loss Drug Prices
Zaid explains Novo Nordisk's cash-price cuts for Wegovy and Ozempic and the introductory offer to broaden access.
Play episode from 02:59
Transcript
